Oxidative stress and heart failure
- PMID: 7494558
- DOI: 10.1007/BF00944786
Oxidative stress and heart failure
Abstract
Various abnormalities have been implicated in the transition of hypertrophy to heart failure but the exact mechanism is still unknown. Thus heart failure subsequent to hypertrophy remains a major clinical problem. Recently, oxidative stress has been suggested to play a critical role in the pathogenesis of heart failure. Here we describe antioxidant changes as well as their significance during hypertrophy and heart failure stages. Heart hypertrophy in rats and guinea pigs, in response to pressure overload, is associated with an increase in 'antioxidant reserve' and a decrease in oxidative stress. Hypertrophied rat hearts show increased tolerance for different oxidative stress conditions such as those imposed by free radicals, hypoxia-reoxygenation and ischemia-reperfusion. On the other hand, heart failure under acute as well as chronic conditions is associated with reduced antioxidant reserve and increased oxidative stress. The latter may have a causal role as suggested by the protection seen with antioxidant treatment in acute as well as in chronic heart failure. It is becoming increasingly apparent that, anytime the available antioxidant reserve in the cell becomes inadequate, myocardial dysfunction is imminent.
Similar articles
-
Role of oxidative stress in transition of hypertrophy to heart failure.J Am Coll Cardiol. 1996 Aug;28(2):506-14. doi: 10.1016/0735-1097(96)00140-4. J Am Coll Cardiol. 1996. PMID: 8800132
-
A relative deficit in antioxidant reserve may contribute in cardiac failure.Can J Cardiol. 1990 Mar;6(2):47-9. Can J Cardiol. 1990. PMID: 2138050
-
Antioxidant and oxidative stress changes in experimental cor pulmonale.Mol Cell Biochem. 2004 May;260(1-2):21-9. doi: 10.1023/b:mcbi.0000026047.48534.50. Mol Cell Biochem. 2004. PMID: 15228082
-
Mitochondrial oxidative stress and dysfunction in myocardial remodelling.Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review.
-
Subcellular remodeling as a viable target for the treatment of congestive heart failure.J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):31-45. doi: 10.1177/107424840601100103. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703218 Review.
Cited by
-
Cardioprotective effect of propofol against oxygen glucose deprivation and reperfusion injury in H9c2 cells.Oxid Med Cell Longev. 2015;2015:184938. doi: 10.1155/2015/184938. Epub 2015 Mar 4. Oxid Med Cell Longev. 2015. PMID: 25821553 Free PMC article.
-
Modulation of angiotensin II signaling following exercise training in heart failure.Am J Physiol Heart Circ Physiol. 2015 Apr 15;308(8):H781-91. doi: 10.1152/ajpheart.00026.2015. Epub 2015 Feb 13. Am J Physiol Heart Circ Physiol. 2015. PMID: 25681422 Free PMC article. Review.
-
Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease.Gut. 2000 Nov;47(5):710-6. doi: 10.1136/gut.47.5.710. Gut. 2000. PMID: 11034590 Free PMC article.
-
Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy.Mediators Inflamm. 2014;2014:147040. doi: 10.1155/2014/147040. Epub 2014 Oct 23. Mediators Inflamm. 2014. PMID: 25400332 Free PMC article.
-
Uric acid correlates to oxidation and inflammation in opposite directions in women.Biomarkers. 2015;20(4):225-31. doi: 10.3109/1354750X.2015.1068852. Biomarkers. 2015. PMID: 26301880 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical